GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Waverley Pharma Inc (TSXV:WAVE) » Definitions » Accounts Receivable

Waverley Pharma (TSXV:WAVE) Accounts Receivable : C$0.14 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Waverley Pharma Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Waverley Pharma's accounts receivables for the quarter that ended in Dec. 2023 was C$0.14 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Waverley Pharma's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 251.40.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Waverley Pharma's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was C$-0.04.


Waverley Pharma Accounts Receivable Historical Data

The historical data trend for Waverley Pharma's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waverley Pharma Accounts Receivable Chart

Waverley Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial 0.67 0.45 0.42 0.19 0.14

Waverley Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.13 0.03 0.13 0.14

Waverley Pharma Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Waverley Pharma Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Waverley Pharma's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.135/0.049*91
=251.40

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Waverley Pharma's accounts receivable are only considered to be worth 75% of book value:

Waverley Pharma's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.053+0.75 * 0.135+0.5 * 0.001-2.089
-0-0)/54
=-0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Waverley Pharma Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Waverley Pharma's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Waverley Pharma (TSXV:WAVE) Business Description

Traded in Other Exchanges
Address
1250 Waverley Street, Suite 4, Winnipeg, MB, CAN, R3T 6C6
Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Capecitabine and Temozolomide, among others.

Waverley Pharma (TSXV:WAVE) Headlines

From GuruFocus

California Senate Approves Wave and Tidal Renewable Energy Bill

By PRNewswire PRNewswire 06-20-2023

Eco Wave Power Global AB (publ) Published Annual Report 2022

By PRNewswire PRNewswire 06-07-2023